Abstract:
A novel compound is provided to show anti-bacterial activity. A composition comprising the same is provided to prevent or treat efficiently bacterial infection or disinfect a non-living object. A compound is represented by the formula(1) of peptide-L-PNA, where the peptide is an amino acid sequence, L is an linker or a bond, and PNA is a peptide nucleic acid and selected from the group consisting of -CGCCCAATAAT-NH2, -TCAGCGTCAGT-NH2, -CCAACATCTCA-NH2 and -TCTCAGTCCCA-NH2, wherein A is N-(2-aminoethyl)-N-(N6-(benzyloxycarbonyl)adenine-9-yl-acetyl)glycine, T is N-(2-aminoethyl)-N-(thymine-1-yl-acetyl)glycine, G is N-(2-aminoethyl)-N-(N2-(benzyloxycarbonyl)guanine-9-yl-acetyl)glycine and C is N-(2-aminoethyl)-N-(N4-(benzyloxycarbonyl)cytosine-1-yl-acetyl)glycine. A composition for preventing or treating bacterial infection comprises the compound and a pharmaceutically acceptable carrier. A method for disinfecting a non-living object comprises a step of contacting a composition for disinfecting the non-living object comprising the compound and a carrier with the non-living object.
Abstract:
A method and a system for community computing are provided to design a model collaborating in a community unit by organically combining persons, computing devices, and services, as a community model is applied to a ubiquitous computing environment. A community purpose part contains a final purpose to be attained by the community. A community skin part supports privacy protection/information hiding in the computing environment probably opening excessive information by encapsulating the community. A community policy part supports an operation of the community by being diversely combined as a policy set for functions of the community. A community member part performs mutual collaboration to attain the final purpose by binding the community. A community action part provides context-based action to be taken by the community member part to attain the final purpose.
Abstract:
본 발명은 커뮤니티의 목적, 정책, 멤버, 멤버 상호간의 작동, 커뮤니티 작동 상황, 커뮤니티 휴면 상황 등이 정의되어 하나의 커뮤니티를 형성하는 커뮤니티 형성 단계; 상기 커뮤니티 형성 단계 이후 커뮤니티가 실제 커뮤니티 멤버를 구성하고 동작해야 할 시점을 기다리는 커뮤니티 대기 단계; 상기 커뮤니티 대기 단계 이후 커뮤니티가 상황 정보를 감시하다가 커뮤니티 작동 상황이 되면 스스로 활성화되어 동작을 시작하는 커뮤니티 동작 단계; 상기 커뮤니티 동작 단계 이후 커뮤니티가 커뮤니티의 목적을 만족시키거나 휴면할 상황이 되면 커뮤니티가 스스로 동작을 일시적으로 멈추고 다음 커뮤니티 동작 단계를 대기하는 커뮤니티 휴면 단계; 및 커뮤니티가 더 이상 동작할 필요가 없는 경우에 스스로 모든 동작을 종료하는 커뮤니티 종료 단계를 포함하는 커뮤니티 컴퓨팅 방법 및 시스템에 관한 것이다. 유비쿼터스, 유비쿼터스 컴퓨팅, 커뮤니티, 커뮤니티 컴퓨팅
Abstract:
A system for supporting the diversity of a ubiquitous computing environment according to the present invention has a message bus including a message broker managing an intermediary role of delivering an actual message between the subsystems and a messaging adaptor managing an interface function between the message broker and the subsystems, wherein the messaging adaptor is installed in the subsystems and includes a first adaptor including a first application port for interfacing with the subsystems, and a second adaptor including a second application port for interfacing with the first adaptor and the broker port operating with the message broker.
Abstract:
본 발명은 인간 신데칸-1 유전자 발현의 RNA 간섭을 유도하는 핵산 분자 및 약제학적으로 허용가능한 담체를 포함하는 자궁 내막암 치료 또는 예방용 조성물 및 그를 인간에 투여하는 단계를 포함하는 자궁 내막암 치료 또는 예방 방법을 제공한다. 신데칸-1, RNA 간섭, shRNAi
Abstract:
A system for supporting the diversity of a ubiquitous computing environment according to the present invention has a message bus including a message broker managing an intermediary role of delivering an actual message between the subsystems and a messaging adaptor managing an interface function between the message broker and the subsystems, wherein the messaging adaptor is installed in the subsystems and includes a first adaptor including a first application port for interfacing with the subsystems, and a second adaptor including a second application port for interfacing with the first adaptor and the broker port operating with the message broker.
Abstract:
A composition for treating or preventing endometrial cancer is provided to inhibit growth of tumor by inhibiting the expression of syndecan-1 in endometrial cancer cell through shRNAi. The prophylactic or preventive composition for endometrial cancer comprises a nucleic acid molecule inducing RNA interference of human syndecan-1 gene expression and a pharmaceutically acceptable carrier. In the composition, the nucleic acid molecule has a sequence described as SEQ ID : NO. 1 or 2 and the human syndecan-1 gene has an NCBI access number of NM_002977.
Abstract translation:提供一种用于治疗或预防子宫内膜癌的组合物,通过shRNAi抑制子宫内膜癌细胞中syndecan-1的表达来抑制肿瘤生长。 用于子宫内膜癌的预防或预防组合物包括诱导人类syndecan-1基因表达的RNA干扰的核酸分子和药学上可接受的载体。 在组合物中,核酸分子具有SEQ ID NO: 1或2,人类syndecan-1基因的NCBI接入号为NM_002977。